Cell MedX Corp. - FORM 10-Q - EX-10.32 - LOAN AGREEMENT AND NOTE PAYABLE DATED FEBRUARY 4, 2016, AMONG CELL MEDX CORP., AND TRADEX CAPITAL CORP. - April 14, 2016

Attached files

file filename
EX-31.2 - CERTIFICATION - Cell MedX Corp.ex312.htm
EX-32.2 - CERTIFICATION - Cell MedX Corp.ex322.htm
EX-31.1 - CERTIFICATION - Cell MedX Corp.ex311.htm
EX-32.1 - CERTIFICATION - Cell MedX Corp.ex321.htm
EX-10.35 - LOAN AGREEMENT AND NOTE PAYABLE DATED MARCH 10, 2016, AMONG CELL MEDX CORP., AND TRADEX CAPITAL CORP. - Cell MedX Corp.ex1035.htm
EX-10.36 - LOAN AGREEMENT AND NOTE PAYABLE DATED MARCH 30, 2016, AMONG CELL MEDX CORP., AND TRADEX CAPITAL CORP. - Cell MedX Corp.ex1036.htm
EX-10.37 - LOAN AGREEMENT AND NOTE PAYABLE DATED MARCH 31, 2016 AMONG CELL MEDX CORP., AND RICHARD N. JEFFS. - Cell MedX Corp.ex1037.htm
EX-10.30 - LOAN AGREEMENT AND NOTE PAYABLE DATED NOVEMBER 5, 2015, AMONG CELL MEDX CORP., AND TRADEX CAPITAL CORP. - Cell MedX Corp.ex1030.htm
EX-10.33 - LOAN AGREEMENT AND NOTE PAYABLE DATED MARCH 2, 2016, AMONG CELL MEDX CORP., AND TRADEX CAPITAL CORP. - Cell MedX Corp.ex1033.htm
10-Q - 10-Q - Cell MedX Corp.form10q.htm
LOAN AGREEMENT
February 4, 2016

Tradex Capital Corp., (the “Lender”) of 888 Dunsmuir Street, Suite #1100, Vancouver, BC, V6C 3K4, advanced USD$50,000 (the “Principal Sum”) to Cell MedX Corp. (the “Borrower”) of 2857 Sumter Valley Circle, Henderson, NV 89052.  The Lender advanced the funds on February 4, 2016.

The Borrower agrees to repay the Principal Sum on demand, together with interest calculated and compounded monthly at the rate of 6% per year (the “Interest”) from February 4, 2016.  The Borrower is liable for repayment for the Principal Sum and accrued Interest and any costs that the Lender incurs in trying to collect the Principal Sum and the Interest.

 
The Borrower will evidence the debt and its repayment of the Principal Sum and the Interest with a promissory note in the attached form.
 
LENDER                                                                      BORROWER
Tradex Capital Corp.                                                Cell MedX Corp.

Per:                                                                               Per:


/s/ William Friesen                                                      /s/ Yanika Silina                                                                      
Authorized Signatory                                                Yanika Silina, CFO



 
 
 

PROMISSORY NOTE

Principal Amount:  USD$50,000                                                                                                                                February 4, 2016


For value received Cell MedX Corp., (the “Borrower”) promises to pay on demand to the order of Tradex Capital Corp. (the “Lender”) the sum of $50,000 lawful money of United States (the “Principal Sum”) together with interest on the Principal Sum from February 4, 2016 (“Effective Date”) both before and after maturity, default and judgment at the Interest Rate as defined below.

For the purposes of this promissory note, Interest Rate means 6 per cent per year.  Interest at the Interest Rate must be calculated and compounded monthly not in advance from and including the Effective Date (for an effective rate of 6.2% per annum calculated monthly), and is payable together with the Principal Sum when the Principal Sum is repaid.

The Borrower may repay the Principal Sum and the Interest in whole or in part at any time.

The Borrower waives presentment, protest, notice of protest and notice of dishonour of this promissory note.





BORROWER
Cell MedX Corp.

Per:


/s/ Yanika Silina

Yanika Silina, CFO


 
 
 

Cell MedX Corp. Reports